Please login to the form below

Not currently logged in
Email:
Password:

Sri Lanka bans reps from state institutions

Sri Lanka bans marketing representatives of private pharmaceutical companies to operate in government medical institutions

Sri Lanka's Ministry of Health has issued a circular prohibiting marketing representatives of private pharmaceutical companies to operate in government medical institutions.

According to ministry sources, marketing representatives will not be allowed to enter government institutions for business purposes from 1 January onwards. The circular holds the head of the institution responsible in case of such entry.

Local media reports have criticised pharmaceutical companies for influencing medical doctors to promote their products, which they say are overpriced.

2nd January 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fendix

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics